Marketing

New data doesn’t dispel legal pressure for OxyContin maker Purdue

Posted on July 19, 2019 by Scott Slater III

Stamford Advocate – OxyContin maker Purdue Pharma accounted for about 3 percent of the prescription opioids produced in the U.S. between 2006 and 2012, according to newly released federal data — but the disclosure of the small market share is unlikely to tamp down the intense legal pressure from the state of Connecticut and hundreds of other plaintiffs.

Who decides what new products are seen? (Op-ed)

Posted on June 25, 2019 by Scott Slater III

Stamford Advocate – Coffee? Coca-Cola? Or both together? On April 24, Advertising Age reported that Coca-Cola is testing a Coke-coffee hybrid beverage product in a few countries and is poised to introduce it into 25 markets. Coffee and Coca-Cola together. Interesting.

The 30-second trick that can make anyone more creative

Posted on May 31, 2019June 3, 2019 by Scott Slater III

Fast Company – If you’re designing a new product or marketing campaign, what’s the better source of creativity: Your brain or your heart? That’s a question posed by the University of Connecticut and the University of Illinois in a new study published in the Journal of Consumer Research.

Purdue Pharma bypasses state drug monitoring

Posted on May 24, 2019 by Scott Slater III

Norwalk Hour – Connecticut’s newly unredacted lawsuit against Purdue Pharma excoriates the owners and former executives of the OxyContin maker for allegedly fueling the opioid crisis. It does not lambast public officials.

Lawsuit: Sackler Emails ‘Shocking and Offensive’ to Opioid Victims

Posted on May 8, 2019May 13, 2019 by Melissa Ferrigno

CT Post – Connecticut Attorney General William Tong released Tuesday an unredacted version of the state’s lawsuit against OxyContin maker Purdue Pharma, revealing emails from 2001 that he said showed company co-owner and former CEO and President Richard Sackler’s “shocking and offensive” disregard for victims of the opioid crisis — an assertion contested by Sackler’s attorney.

Connecticut Turns Up Pressure on OxyContin Maker Purdue Pharma

Posted on April 23, 2019May 7, 2019 by Melissa Ferrigno

CT Post – Connecticut’s expanded lawsuit against Purdue Pharma and its owners positions the state to more aggressively pursue its claims, but does not assure a full redress of its allegations of deceptive marketing and fraudulent finances against the much-maligned OxyContin maker.

British Drug Maker Indivior Indicted On Fraud And Conspiracy Charges In The U.S.

Posted on April 11, 2019 by Scott Slater III

NPR – Share prices for the British drugmaker Indivior plunged today on the London Stock Exchange. The drop came on news that the U.S. Justice Department indicted the company on fraud and conspiracy charges.

XFL still working to clinch TV deal

Posted on March 14, 2019April 2, 2019 by Scott Slater III

The Hour – Eleven months from kickoff, the XFL has its teams, host cities and many of its coaches. It does not have a TV deal — at least not yet.

Vineyard Vines to Launch Target Collection

Posted on March 11, 2019March 15, 2019 by Melissa Ferrigno

Stamford Advocate – Vineyard Vines, the preppy clothing company known for its smiling-whale logo, has launched one of its largest initiatives by teaming up with retailing giant Target.

Many sue OxyContin maker, but not its own city: Stamford

Posted on March 4, 2019April 2, 2019 by Scott Slater III

Westport News – Six of the state’s 10 largest cities, and hundreds of others across the country, have sued OxyContin maker Purdue Pharma. So has Connecticut’s attorney general and more than 30 of his counterparts.

School of Business

About the School

Campuses

News & Events

Contact

Undergraduate Degree

Graduate Programs

MBA Programs

Specialized Masters

Professional Development

Overview

Academic Areas

Faculty & Ph.D.s

Research Centers

Recruit

Centers, Institutes, & Initiatives

Experiential Learning